A research paper published on Patanjali’s Renogrit, a formulation that is effective against cancer drug cisplatin’s damaging effect on kidneys, has been featured among the most notable research studies of 2024. The study titled Renogrit selectively protects against cisplatin‑induced injury in human renal tubular cells and in Caenorhabditis elegans by harmonizing apoptosis and mitophagy, was published in Scientific Reports journal in August 2024.
On this remarkable feat, Acharya Balkrishna stated that the success of the Ayurvedic formulation is a significant step in establishing the scientific credibility of Ayurveda on a global scale. The research paper has been ranked among 100 best papers in the “Scientific Reports” journal of prestigious “Nature Portfolio” publication. Scientific Reports is the 5th most-cited journal globally.
